- Elbit Systems reported a net income of $125.7 million for the second quarter, marking a 60% increase compared to the same period last year when the net income was $78.4 million.
- The company’s revenue for the second quarter climbed to $1.97 billion, reflecting a 21% increase year-over-year.
- Elbit Systems‘ order backlog grew to $23.8 billion, showing a 13% increase from the previous year.
- In terms of market analyst recommendations, there is currently 1 buy and 1 hold, with no sell recommendations for Elbit Systems.
A look at Elbit Systems Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Elbit Systems Ltd., a company specializing in integrated defense systems and military electronic products, shows a promising long-term outlook based on the Smartkarma Smart Scores. With above-average scores in Growth and Momentum, Elbit Systems demonstrates strong potential for future expansion and market performance. Additionally, the company’s resilience score indicates a stable foundation amidst changing economic conditions. While its Value and Dividend scores are moderate, the emphasis on growth and momentum suggests a focus on capitalizing on market opportunities and innovation.
In summary, Elbit Systems Ltd. is positioned to capitalize on its strengths in growth and momentum, indicating a positive trajectory for the company’s future performance in the defense industry. With a strategic emphasis on developing and supporting military electronic systems, Elbit Systems‘ ability to adapt to market trends and capitalize on growth opportunities sets a solid foundation for long-term success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
